Elementis (OTCMKTS:ELMTY) Short Interest Update

Key Points

• Elementis experienced a significant increase in short interest of 200% in July, rising from 100 shares to 300 shares as of July 15th.
• The stock's current price remained unchanged at $8.61, with a twelve-month low matching this price.
• Elementis operates as a specialty chemical company, focusing on Performance Specialties and Personal Care segments, producing additives for various industries.

Elementis (OTCMKTS:ELMTY - ) was the target of a significant growth in short interest in July. As of July 15th, there was short interest totalling 300 shares, a growth of 200.0% from the June 30th total of 100 shares. Based on an average daily trading volume, of 200 shares, the days-to-cover ratio is presently 1.5 days. Approximately 0.0% of the shares of the stock are sold short.

Elementis Stock Performance

Shares of ELMTY stock remained flat at $8.61 during trading hours on Tuesday. The stock had a trading volume of 2 shares, compared to its average volume of 115. Elementis has a twelve month low of $8.61 and a twelve month high of $9.20. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.64 and a quick ratio of 1.48. The business's fifty day moving average price is $7.81 and its 200 day moving average price is $7.45.

About Elementis

Elementis plc operates as a specialty chemical company in the United Kingdom, rest of Europe, North America, and internationally. It operates in two segments, Performance Specialties and Personal Care. The Performance Specialties segment engages in the production of rheological modifiers and additives for decorative and industrial coatings; and production and supply of talc for use in plastics, coatings, technical ceramics, and paper sectors.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.